monoclonal antibody cell signaling technology rrid ab 10693329 fitc rat anti mouse cd45 bd biosciences rrid ab 394610 chemicals (Cell Signaling Technology Inc)
Structured Review
Monoclonal Antibody Cell Signaling Technology Rrid Ab 10693329 Fitc Rat Anti Mouse Cd45 Bd Biosciences Rrid Ab 394610 Chemicals, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monoclonal+rat+anti+mouse+cd45+antibody/CD45+Rat+mAb/pm40628258-647-87-89
Average 93 stars, based on 3 article reviews
Images
Related Articles
Isolation:Article Title: Tumor-Associated Extracellular Microvesicles with Fluorine-Modified Carbohydrate Antigens Trigger a Stronger Antitumor Immune Response. Article Snippet: Abnormal glycosylation is a hallmark of tumor development, and tumor-associated carbohydrate antigens are potential immune targets for tumor therapy.. Tumor-associated extracellular microvesicles are subcellular vesicles released from cell membranes that have immunogenicity similar to that of precursor cells.. However, unmodified tumor-derived microvesicles have weaknesses, such as low immunogenicity, poor biostability, and short half-life in vivo. Incubation:Article Title: Tumor-Associated Extracellular Microvesicles with Fluorine-Modified Carbohydrate Antigens Trigger a Stronger Antitumor Immune Response. Article Snippet: Abnormal glycosylation is a hallmark of tumor development, and tumor-associated carbohydrate antigens are potential immune targets for tumor therapy.. Tumor-associated extracellular microvesicles are subcellular vesicles released from cell membranes that have immunogenicity similar to that of precursor cells.. However, unmodified tumor-derived microvesicles have weaknesses, such as low immunogenicity, poor biostability, and short half-life in vivo. Staining:Article Title: Tumor-Associated Extracellular Microvesicles with Fluorine-Modified Carbohydrate Antigens Trigger a Stronger Antitumor Immune Response. Article Snippet: Abnormal glycosylation is a hallmark of tumor development, and tumor-associated carbohydrate antigens are potential immune targets for tumor therapy.. Tumor-associated extracellular microvesicles are subcellular vesicles released from cell membranes that have immunogenicity similar to that of precursor cells.. However, unmodified tumor-derived microvesicles have weaknesses, such as low immunogenicity, poor biostability, and short half-life in vivo. Recombinant:Article Title: Resolving the design principles that control post-natal vascular growth and scaling. Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Rabbit anti-ERG recombinant monoclonal antibody Abcam RRID: AB_2630401 Rabbit anti-ERG (SP06-04) recombinant monoclonal antibody Thermo Fisher RRID: AB_2809330 Armenian Hamster anti-PECAM (2H8) monoclonal antibody Developmental Studies Hybridoma Bank RRID: AB_2161039 Rabbit anti-Ki67 [SP6] Abcam RRID: AB_302459 Rabbit Alexa Fluor® 647 Anti-Ki67 antibody [SP6] Abcam RRID: AB_302459 Rabbit anti-acetylated alpha tubulin (Lys40) (D20G3) XP® Cell Signaling Technology RRID: AB_10544694 Chicken anti-GFP polyclonal antibody Abcam RRID: AB_300798 Rabbit Living Colors® DsRed polyclonal antibody Takara Bio RRID: AB_10013483 Mouse Alexa Fluor® 647 HA-Tag (6E2) |

